A novel predictor of clinical progression in patients on active surveillance for prostate cancer

INTRODUCTION: Active surveillance (AS) is standard of care in low-risk prostate cancer (PCa). This study describes a novel total cancer location (TCLo) density metric and aims to determine its performance in predicting clinical progression (CP) and grade progression (GP). METHODS: This was a retrosp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can Urol Assoc J
Autors principals: Tan, Guan Hee, Finelli, Antonio, Ahmad, Ardalan, Wettstein, Marian S., Chandrasekar, Thenappan, Zlotta, Alexandre R., Fleshner, Neil E., Hamilton, Robert J., Kulkarni, Girish S., Ajib, Khaled, Nason, Gregory, Perlis, Nathan
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737740/
https://ncbi.nlm.nih.gov/pubmed/31496491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.6122
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars